ICDs Prevent Sudden Death From Hypertrophic Cardiomyopathy - Registry
This article was originally published in The Gray Sheet
A single risk factor for sudden cardiac death in patients with hypertrophic cardiomyopathy may be enough to justify a prophylactic cardioverter defibrillator implant, according to the results of a Medtronic-sponsored registry reported in the July 25 Journal of the American Medical Association
You may also be interested in...
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.